Wealthcare Capital Management’s GSK GSK Stock Holding History

Wealthcare Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-172	Closed	-$10K	–	422
2019 Q4	$10K	Buy	+172	New	+$9.57K	﹤0.01%	189
2017 Q2	–	Sell	-10	Closed	-$1K	–	190
2017 Q1	$1K	Hold	10	–	–	﹤0.01%	171
2016 Q4	$0	Hold	10	–	–	﹤0.01%	199
2016 Q3	$1K	Hold	10	–	–	﹤0.01%	182
2016 Q2	$1K	Hold	10	–	–	﹤0.01%	185
2016 Q1	$0	Hold	10	–	–	﹤0.01%	220
2015 Q4	$0	Hold	10	–	–	﹤0.01%	232
2015 Q3	$0	Sell	10 -232	-96%	-$12.1K	﹤0.01%	307
2015 Q2	$13K	Sell	242 -432	-64%	-$24.3K	﹤0.01%	185
2015 Q1	$39K	Buy	674 +664	+6,640%	+$38.1K	﹤0.01%	298
2014 Q4	$1K	Buy	+10	New	+$559	﹤0.01%	184

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Wealthcare Capital Management's GSK Position: Q1 2020 in Review

Wealthcare Capital Management sold out of GSK (GSK) in Q1 2020, closing a stake of 172 shares — an estimated $10K sold.

Wealthcare Capital Management first reported a position in GSK in Q4 2014 and held it in 11 quarters. The position peaked at $39K in Q1 2015. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

Wealthcare Capital Management reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
Wealthcare Capital Management sold 172 GSK shares in Q1 2020, an estimated $10K.
Wealthcare Capital Management first reported a position in GSK in Q4 2014 and held it in 11 quarters.
Wealthcare Capital Management's GSK position peaked at $39K in Q1 2015.
817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Wealthcare Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.